ATOMWISE INC.

Company Snapshot

Founded: 2012

Entity Type: Private

Region: U.S.

Headquarter: U.S.

Key Geographics: North America

Corporate Address: 250 Sutter Street Suite 650, San Francisco California 94108 U.S. Tel. +1-(650)-449-7925 www.atomwise.com

Company Overview

Atomwise is a biotechnology company that leverages artificial intelligence (AI) and machine learning to accelerate drug discovery and development. The company's innovative platform uses DL algorithms to analyze complex biological data, predicting the effectiveness of potential drug compounds and identifying new therapeutic candidates.

ATOMWISE INC. In Reports

Artificial Intelligence (AI) in Pharmaceuticals: Global Markets

According to our research analyst the artificial intelligence ai in pharmaceutical market includes global revenue ($ Million) for the base year of 2024 and estimated data for 2025 and the forecast period 2026 through...

AI in Biotechnology: Global Markets

Our detailed report on the AI in Biotechnology includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.

AI in Clinical and Molecular Diagnostics Market

BCC Research Market Analyst says global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029.

View All Reports

AI-Based Drug Discovery Company Atomwise Sets Its Sights on Inflammatory Disease Market - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Oct 06, 2023

Read All News

Company's Business Segments

Drug Discovery : The company leverages the power of machine learning and AI to design structure-based drugs and discover small-molecule medicines.

Applications/End User Industries

Healthcare